Huang Yuan, Hu Yunyun, Bao Bingshu
Department of Cardiology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
The First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Endocr Connect. 2023 Oct 3;12(11). doi: 10.1530/EC-23-0291. Print 2023 Nov 1.
Obesity and arterial stiffness are strongly associated with cardiovascular disease; however, their relationship remains controversial.
Body mass index was measured using anthropometric evaluation, and visceral fat area was calculated using an absorptiometry scan.
The data of 5309 participants were collected from NHANES (National Health and Nutrition Examination Survey) (2011-2018). Based on the normal-weight normal visceral fat group that was considered as a reference, ePWV increased in all other groups, with the obese grade 2 visceral obesity group increasing the most by 26.35 cm/s (95% CI: 13.52, 39.18, P < 0.001), followed by normal-weight visceral obesity group 24.43 cm/s (95% CI: 1.88, 46.98, P = 0.035), which was even higher than obese grade 1 visceral obesity (β: 21.16, 95% CI: 9.24, 33.07, P = 0.001), obese grade 2 normal visceral fat group (β: 13.8; 95% CI: 0.10, 27.5, P = 0.048) and overweight visceral obesity group (β: 10.23; 95% CI: 1.89, 18.57, P = 0.018). For the 10-year cardiovascular risk, the obese grade 2 visceral obesity group had a 9.56-fold increase in compared with the control (OR: 10.56, 95% CI: 4.06, 27.51, P < 0.0001). Normal-weight visceral obesity, obese grade 1 visceral obesity, and overweight visceral obesity groups increased by 8.03-fold (OR: 9.03, 95% CI: 2.66, 30.69; P < 0.001), 7.91-fold (OR: 8.91, 95% CI: 3.82, 20.79, P < 0.001), and 7.28-fold (OR: 8.28, 95% CI: 3.19, 21.46, P < 0.001). The risk was lower in the normal visceral fat group. Except for the obese grade 2 normal visceral fat group, there was no significant difference in other groups.
Normal-weight visceral obesity was associated with higher arterial stiffness and 10-year cardiovascular risk.
肥胖与动脉僵硬度与心血管疾病密切相关;然而,它们之间的关系仍存在争议。
采用人体测量评估法测量体重指数,并使用吸收法扫描计算内脏脂肪面积。
从美国国家健康与营养检查调查(NHANES)(2011 - 2018年)收集了5309名参与者的数据。以正常体重正常内脏脂肪组作为参照,其他所有组的增强型脉搏波速度(ePWV)均升高,其中肥胖2级内脏肥胖组升高最多,增加了26.35厘米/秒(95%置信区间:13.52,39.18,P < 0.001),其次是正常体重内脏肥胖组,增加了24.43厘米/秒(95%置信区间:1.88,46.98,P = 0.035),甚至高于肥胖1级内脏肥胖组(β:21.16,95%置信区间:9.24,33.07,P = 0.001)、肥胖2级正常内脏脂肪组(β:13.8;95%置信区间:0.10,27.5,P = 0.048)和超重内脏肥胖组(β:10.23;95%置信区间:1.89,18.57,P = 0.018)。对于10年心血管疾病风险,肥胖2级内脏肥胖组与对照组相比增加了9.56倍(比值比:10.56,95%置信区间:4.06,27.51,P < 0.0001)。正常体重内脏肥胖组、肥胖1级内脏肥胖组和超重内脏肥胖组分别增加了8.03倍(比值比:9.03,95%置信区间:2.66, 30.69;P < 0.001)、7.91倍(比值比:8.91,95%置信区间:3.82,20.79,P < 0.001)和7.28倍(比值比:8.28,95%置信区间:3.19,21.46,P < 0.001)。正常内脏脂肪组的风险较低。除肥胖2级正常内脏脂肪组外,其他组之间无显著差异。
正常体重内脏肥胖与较高的动脉僵硬度和10年心血管疾病风险相关。